Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Further Reading [1] Eli Lilly and Company, 'Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial', Investor press release, May 2026
In clinical trials for branded medications like Ozempic, Wegovy, Mounjaro, and Zepbound, a small percentage of participants with intact gallbladders developed gallstones or gallbladder inflammation (cholecystitis)
For example, patients with a history of thyroid disease, pancreatitis, or certain metabolic conditions may need baseline labs before starting treatment
If you decide to use it, monitor your clinical response carefully over the next few doses
US$ 20.33
US$ 27.28
US$ 27.19
US$ 25.15
US$ 28.06
